DSN asks industry to shape #DSNIndustryIssues discussion
NEW YORK — Drug Store News has lined up a high-caliber roster of retail executives for the 16th annual DSN Industry Issues Summit conference, Dec. 3 at Manhattan’s historic New York Athletic Club.
And for the first time in the event’s history, DSN is issuing an open-call to the industry for discussion points.
The day-long event — which has emerged as an important day on chain pharmacy’s holiday industry week calendar — features exclusive retailer roundtable discussions around three critical areas of the business, including emerging new healthcare technologies, diabetes and chronic care and driving front-end growth.
HELP SHAPE THE DISCUSSION
Drug Store News has also announced a first in the 16-year history of the program — an open call to DrugStoreNews.com users for suggested topics and areas of discussion for our panelists. Comment below and tell us what issues and questions you want us to explore on Dec. 3. Our moderators will pick the best of the best to include in the discussion.
FOLLOW US ON TWITTER
Follow the discussion (@DrugStoreNews) live on Twitter using #DSNIndustryIssues.
Many retail pharmacy organizations are evaluating joining Patient Safety Organizations (PSOs) for the Federal legal protection they provide. We've seen large retailers successfully defend themselves in the court systems potentially avoiding massive fines and/or lawsuits. This is something that's been mandated in the acute care space for hospitals (above 50 beds) in 2017 - is this something your organization has looked at and/or considered?
Given the increased govern mental regulations (mandatory reporting, collection of core measures etc) we are seeing in the acute care space many are anticipating a trickle-down effect to retail pharmacy and for similar types of information around adverse event data collection, HIPAA breaches, and so on to eventually become mandated in this space as well. Is this something leaders of retail pharmacy organizations are anticipating or preparing for? Do they have in-house systems that would be upto snuff to handle this?
Background: The J.D. Power 2014 U.S. Pharmacy Study, released September 18, 2014, demonstrates even the briefest intervention message from a healthcare professional can have a positive impact on patient behaviors. Question: Given workflow challenges, is there a role in pharmacist intervention models for a brief encounter with the patient that provides a generically scripted disease awareness or management message, along with printed branded patient education, resulting in a larger volume of interventions?
Actavis’ Lo Loestrin Fe birth control patent protected through 2029
No comments found
PhRMA names VP communications
No comments found